Researchers at Shinshu University discovered that pterostilbene, a naturally occurring plant compound, reduced fat accumulation in laboratory-grown muscle cells by helping stabilize a protein involved in fat metabolism. The findings suggest a potential avenue for future research into obesity, insulin resistance and healthy aging, although benefits in humans have not been established.
By yourNEWS Media Newsroom
Researchers in Japan have identified a previously unknown mechanism through which pterostilbene, a natural compound found in blueberries, grapes and other berries, may help skeletal muscle cells process fat more efficiently, potentially opening a new direction for research into metabolic health and age-related muscle changes.
The study, conducted by scientists at Shinshu University and published in the September 2026 edition of Food Bioscience, found that pterostilbene reduced the accumulation of fat inside cultured mouse muscle cells by increasing the activity of biological pathways involved in breaking down and using fatty acids.
The findings are significant because excessive fat accumulation in skeletal muscle has been associated with insulin resistance, obesity, aging and other metabolic disorders.
However, the research was conducted in laboratory-grown mouse cells rather than living animals or human participants. It does not establish that eating blueberries, drinking grape juice or taking pterostilbene supplements will reduce muscle fat or prevent metabolic disease in people.
According to the study published in Food Bioscience, researchers discovered that pterostilbene works by stabilizing a protein called peroxisome proliferator-activated receptor delta, or PPARδ, which helps regulate how cells process fatty acids.
Rather than directly stimulating the protein through the mechanism used by many experimental compounds, pterostilbene appeared to prevent the protein from being broken down too quickly.
That allowed more PPARδ to remain available inside the muscle cells, increasing the activity of genes associated with fat metabolism.
The research team was led by Associate Professor Takakazu Mitani of Shinshu University’s Faculty of Agriculture.
Other researchers involved in the study included Maaya Suzuki, Miu Iwasaki, Yasuki Higashimura and Tomohide Takaya.
The scientists were investigating whether naturally occurring food compounds could influence the buildup of fat within skeletal muscle, a process increasingly studied for its relationship to metabolic dysfunction.
Skeletal muscle accounts for a substantial portion of the body’s energy use and plays an essential role in regulating blood glucose and fatty acid metabolism.
Muscle cells can use carbohydrates or fats as energy sources, adjusting their metabolism according to exercise, nutritional status and other physiological demands.
This ability to move between different sources of energy is commonly described as metabolic flexibility.
When that flexibility becomes impaired, the body may become less efficient at processing glucose and fatty acids.
Excess fat can also accumulate within muscle tissue, potentially contributing to abnormalities in insulin signaling and other metabolic processes.
Scientists refer to abnormal fat accumulation in muscle as myosteatosis.
The condition is associated with several health concerns, including reduced muscle quality, metabolic disease and age-related physical decline.
However, not all fat stored within muscle cells is harmful.
Small amounts of intracellular fat serve as an important energy reserve, particularly during prolonged physical activity.
The potential problem arises when fat accumulation exceeds the tissue’s capacity to process or store it appropriately, particularly in the presence of other metabolic abnormalities.
Researchers are therefore interested in identifying ways to improve the regulation of fat within muscle cells rather than eliminating normal fat stores entirely.
Mitani said the absence of treatments specifically targeting myosteatosis helped motivate the investigation.
“We currently lack approved treatments specifically targeting myosteatosis,” Mitani explained in a Sept. 7 announcement from Shinshu University.
“This critical gap led our team to screen food-derived compounds for natural, dietary interventions. During the screening, we identified pterostilbene and focused our investigation on uncovering its precise mechanism of action.”
Pterostilbene belongs to a class of naturally occurring plant chemicals known as stilbenoids.
It is closely related to resveratrol, another plant compound that has been extensively studied for its potential biological effects.
Both substances are classified as polyphenols, a broad group of compounds produced by plants.
Pterostilbene is found naturally in small quantities in blueberries, grapes and certain other plant foods.
Plants produce compounds in this family partly as a response to environmental stresses, including exposure to ultraviolet light and some microorganisms.
Although pterostilbene shares structural similarities with resveratrol, differences in its chemical composition can influence how it interacts with biological systems.
Earlier laboratory and animal studies have examined pterostilbene’s possible effects on inflammation, oxidative stress and lipid metabolism.
Some research has investigated its activity in the liver and adipose tissue, the body’s fat-storage tissue.
Its specific role in regulating fat accumulation within skeletal muscle, however, had received less attention.
To investigate that question, Mitani’s team used C2C12 cells, a laboratory cell line derived from mouse skeletal muscle.
These cells are frequently used in experimental research because they can develop characteristics resembling mature muscle cells.
The researchers exposed the cells to different food-derived compounds and examined their effects on intracellular fat accumulation.
Pterostilbene produced a pronounced reduction in stored lipids while allowing the cells to maintain normal growth and differentiation.
The scientists then conducted additional experiments to determine why the compound had this effect.
One possibility was that pterostilbene prevented fatty acids from entering muscle cells.
However, the researchers found that fatty acid uptake did not significantly change.
Instead, the treated cells appeared to process the fatty acids already present inside them more actively.
The scientists observed increased release of glycerol, a substance produced when stored triglycerides are broken down.
That finding suggested greater intracellular fat breakdown, a process known as lipolysis.
The team also identified increased expression of genes involved in fatty acid oxidation, the process through which cells use fatty acids to produce energy.
Together, the findings indicated that pterostilbene reduced fat accumulation primarily by influencing how the cells processed stored lipids rather than by preventing fat from entering them.
Further investigation identified PPARδ as an important part of the response.
PPARδ belongs to a family of proteins that regulate gene activity in response to metabolic signals.
It plays a role in controlling pathways involved in fatty acid metabolism, energy use and other cellular functions.
When PPARδ signaling increases, cells can activate genes that support fatty acid oxidation.
The researchers initially considered whether pterostilbene directly activated the protein in the same manner as conventional experimental PPARδ agonists.
Those compounds generally bind to the receptor and stimulate its activity.
The experiments revealed a different mechanism.
Pterostilbene did not appear to function as a direct ligand for the protein’s binding domain.
Instead, it increased the amount of PPARδ protein available inside the cells.
The researchers traced that effect to a reduction in the protein’s degradation through a cellular system known as the ubiquitin-proteasome pathway.
The pathway normally helps cells remove proteins that are damaged, unnecessary or scheduled for replacement.
Proteins marked with a small molecule called ubiquitin can be directed toward the proteasome, a cellular structure responsible for breaking them down.
This system is important for regulating protein levels and maintaining normal cellular functions.
In the experiments, pterostilbene appeared to interfere with the process that normally targets PPARδ for degradation.
As a result, the protein remained available for a longer period.
That stabilization increased its ability to regulate genes associated with fatty acid metabolism.
The researchers also found that the protein’s increased availability was associated with greater binding to DNA regions involved in controlling metabolic gene expression.
Gene knockdown experiments provided additional evidence that PPARδ was important to the observed effects.
When researchers reduced the activity of PPARδ, the changes in fat-metabolism-related genes were substantially weakened.
These findings supported the conclusion that pterostilbene’s effects depended significantly on the PPARδ signaling pathway.
The researchers also examined chemical characteristics of pterostilbene associated with its activity.
According to the study, a structural feature involving two methoxy groups appeared to be important for the compound’s metabolic effects.
This detail could help researchers understand why pterostilbene behaves differently from chemically related plant substances.
Identifying such molecular features may also provide useful information for future studies involving other naturally occurring compounds.
The team concluded that stabilizing PPARδ may represent a previously underexplored method of influencing fat metabolism in skeletal muscle.
Mitani said the research could help guide the development of future food-based interventions.
“Our findings establish a scientific framework for developing functional foods and nutritional supplements that target muscle fat metabolism,” he said.
“However, beyond the potential of pterostilbene itself, this work provides an experimental framework for identifying other natural compounds that can stabilize the PPARδ protein.”
The distinction between directly activating a protein and preserving its existing activity is important.
A direct activator attempts to stimulate a biological pathway through receptor binding.
A stabilizing compound may instead increase the amount of a naturally occurring protein available to perform its normal functions.
Both approaches can influence the same pathway, but they involve different molecular interactions.
The researchers believe understanding that difference could help identify additional compounds capable of modifying metabolic processes.
The results may also provide a starting point for studying whether similar effects occur in more complex biological systems.
However, a response observed in cultured cells does not necessarily predict how a substance will behave in the human body.
Compounds consumed through food must first pass through digestion and absorption.
They may then be metabolized by the liver or other tissues before reaching skeletal muscle.
The amount that reaches muscle cells may differ substantially from the concentrations used in laboratory experiments.
Researchers must also determine how long any biological effects persist and whether the compound interacts with other pathways.
The new study did not establish what quantity of blueberries, grapes or other foods would be required to produce comparable effects.
It also did not determine whether ordinary dietary intake of pterostilbene can achieve the concentrations used in the experiments.
That limitation is particularly important because pterostilbene occurs naturally in relatively small amounts in many foods.
A laboratory response to an isolated compound should not be interpreted as evidence that eating a particular quantity of fruit will produce the same effect.
The investigation also did not assess changes in body weight, muscle strength, blood glucose or insulin sensitivity in humans.
Those outcomes would require additional research.
The scientists said future studies should examine whether the same mechanism operates in living animals, including models of obesity and metabolic dysfunction.
Such experiments could help determine whether pterostilbene reaches skeletal muscle in sufficient quantities to influence PPARδ signaling under normal physiological conditions.
They could also provide information about potential side effects and interactions with other biological systems.
If animal research produces encouraging results, carefully designed human studies would be necessary to determine whether the compound provides clinically meaningful benefits.
Researchers would need to examine appropriate doses, long-term safety and measurable changes in metabolic health.
Possible areas of investigation include insulin sensitivity, muscle fat composition and the ability of muscle tissue to use different energy sources.
Those studies would also need to distinguish the effects of pterostilbene from factors such as physical activity, overall diet and changes in body composition.
Exercise remains an established way to improve muscle metabolism.
During physical activity, muscle cells increase their energy demands and use both carbohydrates and fatty acids to support movement.
Regular exercise can improve insulin sensitivity, increase mitochondrial function and influence how skeletal muscle stores and processes fat.
Strength training can also help maintain muscle mass and physical function during aging.
These established benefits provide an important context for interpreting early research on dietary compounds.
Although pterostilbene may eventually prove useful in certain applications, the current evidence does not show that it can replace exercise or established medical treatments for metabolic conditions.
The study’s implications for Type 2 diabetes are also preliminary.
Insulin resistance occurs when cells respond less effectively to insulin, the hormone that helps regulate blood glucose.
Skeletal muscle is particularly important because it is responsible for a substantial portion of glucose uptake after meals.
Metabolic abnormalities within muscle tissue can contribute to impaired glucose regulation.
Excess fat accumulation, particularly in association with certain lipid intermediates and other cellular changes, has been linked to insulin resistance.
However, the relationship is not simply a matter of how much fat is present.
Trained endurance athletes can have substantial amounts of fat stored within muscle cells while maintaining high insulin sensitivity.
Researchers therefore examine the location, turnover and biological effects of muscle lipids rather than treating all intracellular fat as harmful.
The Japanese study contributes to that research by identifying a mechanism that appears to influence how muscle cells process fatty acids.
It does not establish that reducing lipid accumulation through pterostilbene would prevent diabetes.
Similarly, the findings cannot yet support claims that the compound slows aging or reverses age-related muscle deterioration.
Aging affects skeletal muscle through multiple processes, including changes in physical activity, inflammation, mitochondrial function, hormonal regulation and muscle protein metabolism.
Researchers are investigating whether improving fat metabolism could contribute to healthier muscle function during aging.
However, demonstrating such an effect would require studies examining functional outcomes rather than cellular fat levels alone.
The current work is better understood as an investigation into a specific molecular pathway with possible future applications.
It adds to a growing body of scientific literature examining polyphenols and other naturally occurring dietary compounds.
Polyphenols are found in fruits, vegetables, tea and numerous other plant-based foods.
Many have been investigated for antioxidant activity and effects on inflammation, blood vessel function and metabolism.
However, laboratory findings do not always translate into measurable health benefits when people consume the compounds through ordinary diets or supplements.
Differences in absorption, metabolism, dose and biological complexity can substantially alter the results.
Researchers must therefore evaluate individual compounds through multiple stages of investigation before drawing conclusions about their therapeutic value.
Pterostilbene is no exception.
Although previous research has described biological activity involving inflammation, lipid regulation and oxidative stress, those findings do not establish that concentrated pterostilbene supplements are safe or effective for treating metabolic disease.
Supplements can deliver doses substantially higher than those obtained from food.
Their quality, composition and interactions with medications may also vary.
The new study did not assess supplement safety or establish an appropriate dose for human use.
Its authors identified additional testing as a necessary step before practical dietary applications can be considered.
The original research paper, titled “Pterostilbene suppresses intracellular lipid accumulation in C2C12 myocytes via PPARδ stabilization,” appeared in Volume 83 of Food Bioscience.
The article was made available online in July 2026 before appearing in the journal’s September issue.
Researchers affiliated with Shinshu University and collaborating institutions conducted the experiments.
The research received support from Japanese scientific and research funding organizations, including the Japan Society for the Promotion of Science.
The authors reported no competing financial interests or personal relationships that could have influenced the study.
Shinshu University described the findings as a foundation for additional investigations into naturally occurring compounds that affect metabolism.
In the university’s announcement, researchers emphasized that the results must be tested in living organisms before any clinical conclusions can be drawn.
They also identified safety and the selectivity of pterostilbene’s biological effects as important questions for future work.
The discovery provides a possible explanation for how one plant-derived compound can influence fat processing in skeletal muscle cells.
It also identifies PPARδ stabilization as a potential target for further metabolic research.
For consumers, however, the practical implications remain limited.
Blueberries and grapes can be included in a balanced diet because they provide nutrients and other plant compounds, but the new study does not demonstrate that they directly remove excess fat from human muscles.
Nor does it establish that pterostilbene supplements prevent obesity, improve insulin sensitivity or protect against age-related muscle decline.
Those possibilities remain subjects for future investigation.
The study’s principal contribution is the identification of a biological mechanism: pterostilbene appeared to reduce fat accumulation in mouse muscle cells by protecting PPARδ from degradation and increasing the activity of pathways involved in fatty acid metabolism.
Whether that process can be safely reproduced in living animals and ultimately provide measurable benefits for human health remains unknown.
For now, the findings offer researchers a new direction for investigating muscle metabolism rather than a basis for changing dietary or treatment recommendations.
Explainer Infographic
Comments